The role of red cell genotyping in transfusion medicine
By:
Paid access
|Oct 2019References
- Beck ML, Tilzer LL. Red cell compatibility testing: a perspective for the future. Transfus Med Rev 1996;10:118–30.
- Reid ME, Yazdanbakhsh K. Molecular insights into blood groups and implications for blood transfusion. Curr Opin Hematol 1998;5:93–102.
- Zelinski T, Coghlan G, Liu XQ, et al. ABCG2 null alleles define the Jr(a–) blood group phenotype. Nat Genet 2012;44:131–2.
- Svensson L, Hult AK, Stamps R, et al. Forssman expression on human erythrocytes: biochemical and genetic evidence of a new histo blood group system. Blood 2013;121:1459–68.
- Anliker M, von Zabern I, Höchsmann B, et al. A new blood group antigen is defined by anti-CD59, detected in a CD59-deficient patient. Transfusion 2014;54:1817–22.
- Daniels G, Ballif BA, Helias V, et al. Lack of the nucleoside transporter ENT1 results in the Augustine-null blood type and ectopic mineralization. Blood 2015;125:3651–4.
- Bugert P, McBride S, Smith G, et al. Microarray based genotyping for blood groups: comparison of gene array and 5¢-nuclease assay techniques with human platelet antigen as a model. Transfusion 2005;45:654–9.
- Beiboer SH, Wieringa-Jelsma T, Maaskant-Van Wijk PA, et al. Rapid genotyping of blood group antigens by multiplex polymerase chain reaction and DNA microarray hybridisation. Transfusion 2005;45:667–79.
- Hashmi G, Shariff T, Seul M, et al. A flexible array format for large-scale, rapid blood group DNA typing. Transfusion 2005;45:680–8.
- Denomme GA, van Oene M. High-throughput multiplex single-nucleotide polymorphism analysis for red cell and platelet antigen genotypes. Transfusion 2005;45:660–6.
- Avent ND, Martinez A, Flegel WA, et al. The BloodGen project: toward mass-scale comprehensive genotyping of blood donors in the European Union and beyond. Transfusion 2007;47 (1 Suppl):40S–46S.
- Flegel WA, Von Zaben I, Wagner FF. Six years’ experience performing RHD genotyping to confirm D– red blood cell units in Germany for preventing anti-D alloimmunization. Transfusion 2009;49:465–71.
- Jungbauer C, Hobel CM, Schwartz DW, et al. High-throughput multiplex PCR genotyping for 35 red blood cell antigens in blood donors. Vox Sang 2012;102:234–42.
- Veldhuisen B, van der Schoot CE, de Haas M. Blood group genotyping: from patient to high throughput donor screening. Vox Sang 2009;97:198–206.
- Reid ME, Denomme GA. DNA-based methods in the immunohematology reference laboratory. Transfus Apher Sci. 2011;44:65–72.
- Meyer S, Vollmert C, Trost N, et al. High-throughput Kell, Kidd, and Duffy matrix-assisted laser desorption/ionization time-of-flight mass spectrometry-based blood group genotyping of 4000 donors shows close to full concordance with serotyping and detects new alleles. Transfusion 2014;54:3198–207.
- Sandler SG, Keller J, Horn T, et al. A model for integrating molecular-based testing in transfusion services. Blood Transfusion 2015. DOI 10.2450/2015.0070-15.
- Sloan SR. Transfusion for patients with sickle cell disease at Children’s Hospital Boston. Immunohematology 2012;28: 17–9.
- Shafi H, Abumuhor I, Klapper E. How we incorporate molecular typing of donors and patients into our hospital transfusion service. Transfusion 2014;54:1212–9.
- International Society of Blood Transfusion. Red cell immunogenetics and blood group terminology. www.isbtweb. org/working–parties/red–cell–immunogenetics–and–blood– group–terminology/.
- Blumenfeld OO, Patnaik SK. Allelic genes of blood group antigens: a source of human mutations and cSNPs documented in the Blood Group Antigen Gene Mutation Database. Hum Mutat 2004;23:8–16.
- Daniels G, Finning K, Martin P. Noninvasive fetal blood grouping: present and future. Clin Lab Med 2010;30:431–42.
- Reid ME. DNA analysis to find rare blood donors when antisera is not available. Vox Sang 2002;83(Suppl 1):91–3.
- Olsson ML, Smythe JS, Hansson C, et al. The Fy(x) phenotype is associated with a missense mutation in the Fy(b) allele predicting Arge89Cys in the Duffy glycoprotein. Br J Haematol 1998;103:1184–91.
- Londero D, Fiorino M, Viotti V, et al. Molecular RH blood group typing of serologically D–/CE+ donors: the use of a polymerase chain reaction specific primer test kit with pooled samples. Immunohematology 2011;27:25–8.
- El Kenz H, Efira A, Le PQ, et al. Transfusion support of autoimmune hemolytic anemia: how could the blood group genotyping help? Transl Res 2014;163:36–42.
- Reid ME, Rios M, Powell VI, et al. DNA from blood samples can be used to genotype patients who have recently received a transfusion. Transfusion 2000;40:48–53.
- Arnoni CP, Latini FR, Muniz JG, et al. How do we identify RHD variants using a practical molecular approach? Transfusion 2014;54:962–9.
- Reid ME. Applications of DNA-based assays in blood group antigen and antibody identification. Transfusion 2003;43: 1748–57.
- Fasano RM, Monaco A, Meier ER, et al. RH genotyping in a sickle cell disease patient contributing to hematopoietic stem cell transplantation donor selection and management. Blood 2010;116:2836–8.
- Hashmi G, Shariff T, Zhang Y, et al. Determination of 24 minor red blood cell antigens for more than 2000 blood donors by high throughput DNA anaysis. Transfusion 2007;47:736–47.
- Storry JR, Olsson ML, Reid ME. Application of DNA analysis to the quality assurance of reagent red cells. Transfusion 2007;47(Suppl 1):73S–78S.
- Singleton BK, Burton NM, Green C, et al. Mutations in EKLF/ KLF1 form the molecular basis of the rare blood group In(Lu) phenotype. Blood 2008;112:2081–8.
- Pirelli KJ, Pietz BC, Johnson ST, et al. Molecular determination of RHD zygosity: predicting risk of hemolytic disease of the fetus and newborn related to anti-D. Prenat Diagn 2010; 30:1207–12.
- Chou ST, Jackson T, Vege S, et al. High prevalence of red blood cell alloimmunization in sickle cell disease despite transfusion from Rh-matched minority donors. Blood 2013;122:1062–71.
- Spanos, T, Karageorga M, Ladis V, et al. Red cell alloantibodies in patients with thalassemia. Vox Sang 1990;58:50–5.
- Casas J, Friedman DF, Jackson T, et al. Changing practice: red blood cell typing by molecular methods for patients with sickle cell disease. Transfusion 2015;55(6 Pt 2):1388–93.
- Yawn BP, Buchanan GR, Afenyi-Annan AN, et al. Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members. JAMA 2014;312:1033–48.
- Klapper E, Zhang Y, Figueroa P, et al. Transfusion Practice: Toward extended phenotype matching: a new operational paradigm for the transfusion service. Transfusion 2010;50: 536–46.
- Meny GM. Transfusion protocols for patients with sickle cell disease: working toward consensus? Immunohematology 2012; 28:1–2.
- Sandler SG, Flegel WA, Westhoff CM, et al. It’s time to phase in RHD genotyping for patients with a serological weak D phenotype. Transfusion 2015;55:680–9.
- Flegel WA, Gottschall JL, Denomme GA. Implementing mass-scale red cell genotyping at a blood center. Transfusion 2015. Jun 20. doi: 10.1111/trf.13168.
- Finning K, Martin P, Daniels G. A clinical service in the UK to prevent fetal Rh (rhesus) D blood group using free fetal DNA in maternal plasma. Ann N Y Acad Sci 2004;1022:119–23.
- Scheffer PG, van der Schoot CE, Page-Christiaens GC, et al. Noninvasive fetal blood group genotyping of rhesus D, c, E and of K in alloimmunised pregnant women: evaluation of a 7-year experience. BJOG 2011;118:1340–8.
- Westhoff CM. The potential of blood group genotyping for transfusion medicine practice. Immunohematology 2008;24: 190–5.
- Flickinger C. REGGI and The American Rare Donor Program. Transfus Med Hemother 2014;41:342–5.
- Revelli N, Villa MA, Paccapelo C, et al. The Lombardy Rare Donor Programme. Blood Transfus 2014;12(Suppl 1): S249–55.
- Latini FR, Gazito D, Arnoni CP, et al. A new strategy to identify rare blood donors: single polymerase chain reaction multiplex SnaPshot reaction for detection of 16 rare blood group alleles. Blood Transfus 2014;12(Suppl 1):S256–63.
- Jiao W, Liao X, Li H, et al. Rare blood donors screening by multiplex PCR methods in Chinese Zhuang and Dong population and pedigree analysis. Int J Clin Exp Med 2015; 8:3777–84.
- U.S. Census Bureau. Census Brief: The Two or More Races Population: 2010. http://www.census.gov/prod/cen2010/ briefs/c2010br–13.pdf.
- Daniels G, van der Schoot CE, Olsson ML. Report of the Fourth International Workshop on molecular blood group genotyping. Vox Sang 2011;101:327–32.
- Denomme GA, Westhoff CM, Castilho LM, et al. Consortium for Blood Group Genes (CBGG): 2009 report. Immunohematology 2010;26:47–50.
- Flegel WA, Chiosea I, Sachs UJ, et al. External quality assessment in molecular immunohematology: the INSTAND proficiency test program. Transfusion 2013;53(11 Suppl 2): 2850–8.
- Delaney M. Proficiency testing for blood group genotyping. Transfusion 2013;53(11 Suppl 2):2847–9.
- Boyle J, Thorpe SJ, Hawkins JR, et al. International reference reagents to standardise blood group genotyping: evaluation of candidate preparations in an international collaborative study. Vox Sang 2013;104:144–52.
- College of American Pathologists. Surveys and Excel programs. http://www.cap.org/web/home/lab/proficiency–testing/ surveys–and–excelprograms?_afrLoop=250663778210629# %40%3F_afrLoop%3D250663778210629%26_adf.ctrl–state %3Dohs13gzly_25.
- AABB. AABB accredited molecular testing laboratories. http:// www.aabb.org/sa/facilities/Pages/MolTestAccrFac.aspx.
- Hopp K, Weber K, Bellissimo D, et al. High-throughput red blood cell antigen genotyping using a nanofluidic real-time polymerase chain reaction platform. Transfusion 2010;50: 40–6.
- Denomme GA, Schanen MJ. Mass-scale donor red cell genotyping using real-time array technology. Immunohematology 2015;31:69–74.
- McBean RS, Hyland CA, Flower RL. Blood group genotyping: the power and limitations of the Hemo ID Panel and MassARRAY platform. Immunohematology 2015;31:75–80.
- Latini FRM, Castilho LM. An overview of the use of SNaPshot for genotyping blood group antigens. Immunohematology 2015;31:53–57.
- Goldman M, Nogués N, Castilho LM. An overview of the Progenika ID CORE XT: an automated genotyping platform based on a fluidic microarray system. Immunohematology 2015;31:62–68.
- Veldhuisen B, van der Schoot CE, de Haas M. Multiplex ligation-dependent probe amplification (MLPA) assay for blood group genotyping, copy number quantification, and analysis of RH variants. Immunohematology 2015;31:58–61.
- Paccapelo C, Truglio F, Villa MA, et al. HEA BeadChip™ technology in immunohematology. Immunohematology 2015; 31:81–90.
DOI: https://doi.org/10.21307/immunohematology-2019-069 | Journal eISSN: 1930-3955 | Journal ISSN: 0894-203X
Language: English
Page range: 49 - 52
Published on: Oct 26, 2019
Published by: American National Red Cross
In partnership with: Paradigm Publishing Services
Publication frequency: 4 times per year
Related subjects:
© 2019 M.A. Keller, published by American National Red Cross
This work is licensed under the Creative Commons License.